Circulating tumor cells (CTCs) originate from the primary tumor mass and enter into the
peripheral bloodstream. Compared to other “liquid biopsy” portfolios such as exosome …

Increasing evidence suggests that circulating tumour cells (CTCs) are responsible for
metastatic relapse and this has fuelled interest in their detection and quantification. Although …

This work reports a microfluidic device with deterministic lateral displacement (DLD) arrays
allowing rapid and label-free cancer cell separation and enrichment from diluted peripheral …

Background Enumeration of circulating tumor cells (CTCs) may be valuable for prognostic
assessment in lung cancer patients. In this study, we report the clinical significance of CTCs …

The primary cause of tumor-related death in breast cancer (BC) is still represented by distant
metastasization. The dissemination of tumor cells from the primary tumor to distant sites …

Localized and metastatic cancers give rise to circulating tumor cells (CTCs) which are
detectable in the bloodstream. Recent studies have highlighted the prognostic significance …

Despite the progress made in the early detection and treatment of prostate adenocarcinoma,
the metastatic lesions from this tumor are incurable. We used genome-wide expression …

Circulating tumor cells (CTCs) are recognized as a candidate biomarker with strong
prognostic and predictive potential in metastatic disease. Filtration-based enrichment …

Circulating tumor cells (CTCs) play a central role in tumor dissemination and metastases,
which are ultimately responsible for most cancer deaths. Technologies that allow for …

Recent evidence indicates that cancer cells, even in the absence of a primary tumor,
recirculate from established secondary lesions to further seed and colonize skeleton and …